{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:46:10Z","timestamp":1794987970892,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T00:00:00Z","timestamp":1297814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00405-011-1496-z","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T21:29:42Z","timestamp":1297805382000},"page":"1219-1225","source":"Crossref","is-referenced-by-count":37,"title":["Bisphosphonate-induced osteonecrosis of the external ear canal: a retrospective study"],"prefix":"10.1007","volume":"268","author":[{"given":"K.","family":"Froelich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Radeloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mlynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. H.","family":"Kleinsasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,16]]},"reference":[{"key":"1496_CR1","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1055\/s-2005-916355","volume":"130","author":"B Steiner","year":"2005","unstructured":"Steiner B, Lenz JH, Gundlach KK, Freund M (2005) Osteonecrosis of the jaws during treatment with bisphosphonates: diagnosis and therapy. Dtsch Med Wochenschr 130:2142\u20132145","journal-title":"Dtsch Med Wochenschr"},{"key":"1496_CR2","doi-asserted-by":"crossref","unstructured":"Fleisch H, Russell RG, Bisaz S, Casey PA, M\u00fchlbauer RC (1968) The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution. Calcif Tissue Res Suppl: 10\u201310a","DOI":"10.1007\/BF02065192"},{"key":"1496_CR3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/er.19.1.80","volume":"19","author":"H Fleisch","year":"1998","unstructured":"Fleisch H (1998) Bisphosphonates: mechanisms of action. Endocrine Rev 19:80\u2013100","journal-title":"Endocrine Rev"},{"key":"1496_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/bcr414","volume":"4","author":"H Fleisch","year":"2002","unstructured":"Fleisch H (2002) Development of bisphosphonates. Breast Cancer Res 4:30\u201334","journal-title":"Breast Cancer Res"},{"key":"1496_CR5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.165.3899.1262","volume":"165","author":"H Fleisch","year":"1969","unstructured":"Fleisch H, Russell RG, Francis MD (1969) Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science 165:1262\u20131264","journal-title":"Science"},{"key":"1496_CR6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.165.3899.1264","volume":"165","author":"MD Francis","year":"1969","unstructured":"Francis MD, Russell RG, Fleisch H (1969) Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science 165:1264\u20131266","journal-title":"Science"},{"key":"1496_CR7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1601-0825.2007.01381.x","volume":"14","author":"J Sarin","year":"2008","unstructured":"Sarin J, DeRossi SS, Akintoye SO (2008) Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis. Oral Dis 14:277\u2013285","journal-title":"Oral Dis"},{"key":"1496_CR8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12105-007-0022-5","volume":"1","author":"YF Suleman","year":"2007","unstructured":"Suleman YF, Meer S, Lurie R (2007) Bisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report. Head Neck Pathol 1:156\u2013164","journal-title":"Head Neck Pathol"},{"key":"1496_CR9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","volume":"24","author":"A Badros","year":"1996","unstructured":"Badros A, Weikel D, Salama A et al (1996) Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 24:945\u2013952","journal-title":"J Clin Oncol"},{"key":"1496_CR10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/cncr.24119","volume":"115","author":"C Walter","year":"2009","unstructured":"Walter C, Al-Nawas B, du Bois A, Buch L, Harter P, Gr\u00f6tz KA (2009) Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients. Cancer 115:1631\u20131637","journal-title":"Cancer"},{"key":"1496_CR11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1067\/mlc.2000.109757","volume":"136","author":"Y Abe","year":"2000","unstructured":"Abe Y, Kawakami A, Nakashima T et al (2000) Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells. J Lab Clin Med 136:344\u2013354","journal-title":"J Lab Clin Med"},{"key":"1496_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2003.08.011","volume":"477","author":"F Itoh","year":"2003","unstructured":"Itoh F, Aoyagi S, Furihata-Komatsu H et al (2003) Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures. Eur J Pharmacol 477:9\u201316","journal-title":"Eur J Pharmacol"},{"issue":"6 Suppl1","key":"1496_CR13","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00000421-200212001-00002","volume":"25","author":"JR Green","year":"2002","unstructured":"Green JR, Cl\u00e9zardin P (2002) Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis. Am J Clin Oncol 25(6 Suppl1):S3\u2013S9","journal-title":"Am J Clin Oncol"},{"key":"1496_CR14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","volume":"144","author":"SB Woo","year":"2006","unstructured":"Woo SB, Hellstein JW, Kalmar JR (2006) Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753\u2013761","journal-title":"Ann Intern Med"},{"key":"1496_CR15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"1496_CR16","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567\u20131575","journal-title":"J Oral Maxillofac Surg"},{"key":"1496_CR17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","volume":"44","author":"T Boonyapakorn","year":"2008","unstructured":"Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G (2008) Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 44:857\u2013869","journal-title":"Oral Oncol"},{"key":"1496_CR18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","volume":"23","author":"AO Hoff","year":"2008","unstructured":"Hoff AO, Toth BB, Altundag K et al (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23:826\u2013836","journal-title":"J Bone Miner Res"},{"key":"1496_CR19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2008.11.029","volume":"112","author":"T Fehm","year":"2009","unstructured":"Fehm T, Beck V, Banys M, Lipp HP et al (2009) Bisphosphonate-induced osteonecrosis of the jaw (ONJ): incidence and risk factors in patients with breast cancer and gynecological malignancies. Gynecol Oncol 112:605\u2013609","journal-title":"Gynecol Oncol"},{"key":"1496_CR20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/S0022215100137041","volume":"111","author":"BN Kumar","year":"1997","unstructured":"Kumar BN, Walsh RM, Sinha A, Courteney-Harris RG, Carlin WV (1997) Benign necrotizing osteitis of the external auditory meatus. J Laryngol Otol 111:269\u2013270","journal-title":"J Laryngol Otol"},{"key":"1496_CR21","first-page":"E18","volume":"88","author":"A Tsikoudas","year":"2009","unstructured":"Tsikoudas A, Davis BC (2009) Benign necrotizing otitis externa. Ear Nose Throat J 88:E18","journal-title":"Ear Nose Throat J"},{"key":"1496_CR22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00005537-199704000-00010","volume":"107","author":"M Wolf","year":"1997","unstructured":"Wolf M, Nusem-Horowitz S, Zwas ST, Horowitz A, Kronenberg J (1997) Benign osteonecrosis of the external ear canal. Laryngoscope 107:478\u2013482","journal-title":"Laryngoscope"},{"key":"1496_CR23","first-page":"302","volume":"17","author":"R Youngs","year":"1988","unstructured":"Youngs R, Kwok P, Hawke M (1988) Benign osteitis of the external auditory meatus. J Otolaryngol 17:302\u2013307","journal-title":"J Otolaryngol"},{"key":"1496_CR24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"BG Durie","year":"1975","unstructured":"Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36:842\u2013854","journal-title":"Cancer"},{"key":"1496_CR25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(69)92293-4","volume":"2","author":"CA Bassett","year":"1969","unstructured":"Bassett CA, Donath A, Macagno F, Preisig R, Fleisch H, Francis MD (1969) Diphosphonates in the treatment of myositis ossificans. Lancet 2:845","journal-title":"Lancet"},{"key":"1496_CR26","first-page":"574","volume":"78","author":"J Jowsey","year":"1971","unstructured":"Jowsey J, Riggs BL, Kelly PJ, Hoffman DL, Bordier P (1971) The treatment of osteoporosis with disodium ethane-1, 1-diphosphonate. J Lab Clin Med 78:574\u2013584","journal-title":"J Lab Clin Med"},{"key":"1496_CR27","first-page":"66","volume":"55","author":"RG Russell","year":"1973","unstructured":"Russell RG, Smith R (1973) Diphosphonates. Experimental and clinical aspects. J Bone Joint Surg Br 55:66\u201386","journal-title":"J Bone Joint Surg Br"},{"key":"1496_CR28","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(71)91447-4","volume":"1","author":"R Smith","year":"1971","unstructured":"Smith R, Russell RG, Bishop M (1971) Diphosphonates and Paget\u2019s disease of bone. Lancet 1:945\u2013947","journal-title":"Lancet"},{"key":"1496_CR29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3899\/jrheum.080759","volume":"36","author":"AA Khan","year":"2009","unstructured":"Khan AA, S\u00e1ndor GK, Dore E (2009) Canadian Taskforce on osteonecrosis of the Jaw: bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 36:478\u2013490","journal-title":"J Rheumatol"},{"key":"1496_CR30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1601-0825.2009.01568.x","volume":"15","author":"ME Sarasquete","year":"2009","unstructured":"Sarasquete ME, Gonz\u00e1lez M, San Miguel JF, Garc\u00eda-Sanz R (2009) Bisphosphonate-related osteonecrosis: genetic and acquired risk factors. Oral Dis 15:382\u2013387","journal-title":"Oral Dis"},{"key":"1496_CR31","first-page":"475","volume":"5","author":"IJ Diel","year":"2007","unstructured":"Diel IJ, Bergner R, Gr\u00f6tz KA (2007) Adverse effects of bisphosphonates: current issues. J Support Oncol 5:475\u2013482","journal-title":"J Support Oncol"},{"key":"1496_CR32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","volume":"104","author":"CA Migliorati","year":"2005","unstructured":"Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104:83\u201393","journal-title":"Cancer"},{"key":"1496_CR33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00784-009-0266-4","volume":"14","author":"C Walter","year":"2010","unstructured":"Walter C, Klein MO, Pabst A, Al-Nawas B, Duschner H, Ziebart T (2010) Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Investig 14:35\u201341","journal-title":"Clin Oral Investig"},{"key":"1496_CR34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/annonc\/mdl408","volume":"18","author":"D Aguiar Bujanda","year":"2007","unstructured":"Aguiar Bujanda D, Bohn Sarmiento U, Cabrera Su\u00e1rez MA, Aguiar Morales J (2007) Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis. Ann Oncol 18:556\u2013560","journal-title":"Ann Oncol"},{"key":"1496_CR35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","volume":"35","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, for the Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral, Maxillofacial Surgeons (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw\u20142009 update. Aust Endod J 35:119\u2013130","journal-title":"Aust Endod J"},{"key":"1496_CR36","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.clinthera.2007.08.008","volume":"29","author":"M Pazianas","year":"2007","unstructured":"Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P (2007) A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 29:1548\u20131558","journal-title":"Clin Ther"},{"key":"1496_CR37","doi-asserted-by":"crossref","unstructured":"Ziebart T, Pabst A, Klein MO, K\u00e4mmerer P, Gauss L, Br\u00fcllmann D, Al-Nawas B, Walter C et al. (2009) Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro. Clin Oral Investig [Epub ahead of print]","DOI":"10.1007\/s00784-009-0365-2"},{"key":"1496_CR38","first-page":"1080","volume":"8","author":"D Santini","year":"2002","unstructured":"Santini D, Vincenzi B, Avvisati G, Dicuonzo G et al (2002) Pamidronate induces modifications of circulating angiogenetic factors in cancer patients. Clin Cancer Res 8:1080\u20131084","journal-title":"Clin Cancer Res"},{"key":"1496_CR39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2141.2008.07504.x","volume":"144","author":"MA Scheper","year":"2009","unstructured":"Scheper MA, Badros A, Chaisuparat R, Cullen KJ, Meiller TF (2009) Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol 144:667\u2013676","journal-title":"Br J Haematol"},{"key":"1496_CR40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","volume":"66","author":"R Landesberg","year":"2008","unstructured":"Landesberg R, Cozin M, Cremers S et al (2008) Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 66:839\u2013847","journal-title":"J Oral Maxillofac Surg"},{"key":"1496_CR41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00784-009-0312-2","volume":"14","author":"MJ Simon","year":"2010","unstructured":"Simon MJ, Niehoff P, Kimmig B, Wiltfang J, A\u00e7il Y (2010) Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment. Clin Oral Investig 14:51\u201358","journal-title":"Clin Oral Investig"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-011-1496-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-011-1496-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-011-1496-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T15:26:14Z","timestamp":1560007574000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-011-1496-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,16]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1007\/s00405-011-1496-z","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,16]]}}}